Genomictree Inc. (KOSDAQ:228760)
South Korea
· Delayed Price · Currency is KRW 15,720
+500 (3.29%)
Apr 1, 2025, 3:30 PM KST
Genomictree Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Operating Revenue | 2,362 | 3,418 | 29,866 | 5,140 | 1,239 | Upgrade
|
| Other Revenue | - | 0 | - | - | - | Upgrade
|
| Revenue | 2,362 | 3,418 | 29,866 | 5,140 | 1,239 | Upgrade
|
| Revenue Growth (YoY) | -30.89% | -88.55% | 481.09% | 314.87% | 339.89% | Upgrade
|
| Cost of Revenue | 3,108 | 3,720 | 4,891 | 2,641 | 1,193 | Upgrade
|
| Gross Profit | -745.56 | -301.62 | 24,974 | 2,499 | 46.03 | Upgrade
|
| Selling, General & Admin | 8,757 | 10,936 | 14,024 | 8,524 | 8,242 | Upgrade
|
| Research & Development | 4,942 | 4,366 | 5,446 | 2,812 | 3,510 | Upgrade
|
| Other Operating Expenses | 267.92 | 894.91 | 223.09 | 384.93 | 18.63 | Upgrade
|
| Operating Expenses | 14,568 | 17,002 | 22,569 | 12,354 | 12,455 | Upgrade
|
| Operating Income | -15,313 | -17,303 | 2,405 | -9,855 | -12,409 | Upgrade
|
| Interest Expense | -294.65 | -2,054 | -5,382 | -4,606 | -1,668 | Upgrade
|
| Interest & Investment Income | 3,361 | 4,829 | 3,610 | 4,147 | 1,783 | Upgrade
|
| Currency Exchange Gain (Loss) | 565.25 | -21.87 | 498.93 | 831.9 | 52.23 | Upgrade
|
| Other Non Operating Income (Expenses) | 468.31 | 817.71 | -4,682 | 112.85 | -217.75 | Upgrade
|
| EBT Excluding Unusual Items | -11,214 | -13,733 | -3,550 | -9,369 | -12,459 | Upgrade
|
| Gain (Loss) on Sale of Investments | 828.71 | -328.33 | -2,097 | -2,072 | 728.2 | Upgrade
|
| Gain (Loss) on Sale of Assets | -4.46 | - | -92.05 | 17.1 | 8.45 | Upgrade
|
| Other Unusual Items | - | 4,558 | 2,045 | - | - | Upgrade
|
| Pretax Income | -10,389 | -9,503 | -3,693 | -11,424 | -11,722 | Upgrade
|
| Income Tax Expense | 1.09 | -496.61 | 2,544 | 0.92 | 0.94 | Upgrade
|
| Earnings From Continuing Operations | -10,390 | -9,007 | -6,237 | -11,425 | -11,723 | Upgrade
|
| Minority Interest in Earnings | 148.02 | 250.69 | -393.43 | - | -71.83 | Upgrade
|
| Net Income | -10,242 | -8,756 | -6,631 | -11,425 | -11,795 | Upgrade
|
| Net Income to Common | -10,242 | -8,756 | -6,631 | -11,425 | -11,795 | Upgrade
|
| Shares Outstanding (Basic) | 24 | 22 | 21 | 21 | 20 | Upgrade
|
| Shares Outstanding (Diluted) | 24 | 27 | 21 | 21 | 20 | Upgrade
|
| Shares Change (YoY) | -9.92% | 26.28% | 1.68% | 3.30% | 4.57% | Upgrade
|
| EPS (Basic) | -428.94 | -390.66 | -315.89 | -553.38 | -590.16 | Upgrade
|
| EPS (Diluted) | -429.00 | -448.80 | -316.00 | -553.38 | -590.16 | Upgrade
|
| Free Cash Flow | -16,118 | -11,120 | 2,523 | -18,593 | -12,926 | Upgrade
|
| Free Cash Flow Per Share | -674.99 | -419.50 | 120.20 | -900.62 | -646.74 | Upgrade
|
| Gross Margin | -31.56% | -8.82% | 83.62% | 48.62% | 3.72% | Upgrade
|
| Operating Margin | -648.24% | -506.25% | 8.05% | -191.75% | -1001.62% | Upgrade
|
| Profit Margin | -433.57% | -256.17% | -22.20% | -222.28% | -952.10% | Upgrade
|
| Free Cash Flow Margin | -682.29% | -325.32% | 8.45% | -361.76% | -1043.37% | Upgrade
|
| EBITDA | -14,116 | -16,125 | 3,740 | -8,833 | -11,501 | Upgrade
|
| EBITDA Margin | - | - | 12.52% | -171.86% | - | Upgrade
|
| D&A For EBITDA | 1,198 | 1,178 | 1,335 | 1,022 | 907.92 | Upgrade
|
| EBIT | -15,313 | -17,303 | 2,405 | -9,855 | -12,409 | Upgrade
|
| EBIT Margin | - | - | 8.05% | -191.75% | - | Upgrade
|
| Advertising Expenses | 871.86 | 932.39 | 964.91 | 1,119 | 2,228 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.